1. 15786 POINTS
    Bob VineyardPRO
    Founder, Georgia Medicare Plans, Atlanta,GA
    To my knowledge, Lucentis is not yet on the approved list for Medicare prescription drug plans. It was not listed on the Medicare drug formulary finder which is a good indication is not covered.

    Lucentis is used to treat macular degeneration. In tests it has proven no more effective than Bevacizuman which is about $42 per dose vs $1600 for Lucentis.
    Answered on April 30, 2013
  2. Did you find these answers helpful?

Add Your Answer To This Question

You must be logged in to add your answer.

<< Previous Question
Questions Home
Next Question >>